127 related articles for article (PubMed ID: 36221360)
1. The controversial expression of SOX2 in gastric cancer and its correlation with Helicobacter pylori infection: A meta-analysis.
Li N; Pang Y; Sang J; Sun Y; Hou W
Medicine (Baltimore); 2022 Oct; 101(40):e30886. PubMed ID: 36221360
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression.
Asonuma S; Imatani A; Asano N; Oikawa T; Konishi H; Iijima K; Koike T; Ohara S; Shimosegawa T
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G312-22. PubMed ID: 19520737
[TBL] [Abstract][Full Text] [Related]
3. SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis.
Zhang X; Yu H; Yang Y; Zhu R; Bai J; Peng Z; He Y; Chen L; Chen W; Fang D; Bian X; Wang R
J Gastrointest Surg; 2010 Aug; 14(8):1220-6. PubMed ID: 20532662
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells.
Camilo V; Barros R; Sousa S; Magalhães AM; Lopes T; Mário Santos A; Pereira T; Figueiredo C; David L; Almeida R
Carcinogenesis; 2012 Oct; 33(10):1985-92. PubMed ID: 22791809
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma.
Na YJ; Shim KN; Joo YH; Kim SE; Jung HK; Jung SA; Cho MS
Korean J Gastroenterol; 2015 Aug; 66(2):75-84. PubMed ID: 26289240
[TBL] [Abstract][Full Text] [Related]
6. Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer.
Wang F; Sun G; Zou Y; Zhong F; Ma T; Li X
PLoS One; 2013; 8(5):e62440. PubMed ID: 23667477
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the correlation between P27 expression and Helicobacter pylori infection in gastric cancer.
Li L; Wu W; Zheng W; Hui Q; Zhao C
APMIS; 2022 Jan; 130(1):21-25. PubMed ID: 34741767
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a single-center, large-volume study in Korea.
Park JC; Lee YC; Kim JH; Kim YJ; Lee SK; Shin SK; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2010 Mar; 17(3):829-37. PubMed ID: 19882188
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the thermodynamic drivers of the interaction between the high mobility group box domain of Sox2 and bacterial lipopolysaccharide.
Hewitt PH; Pianim ED; DiCesare NA; Gray C; Leong TT; Sakai K; Bernal JV; Shetty SS; Malarkey CS
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183106. PubMed ID: 31669571
[TBL] [Abstract][Full Text] [Related]
10. CDX1 Expression Induced by CagA-Expressing
Choi SI; Yoon C; Park MR; Lee D; Kook MC; Lin JX; Kang JH; Ashktorab H; Smoot DT; Yoon SS; Cho SJ
Mol Cancer Res; 2019 Nov; 17(11):2169-2183. PubMed ID: 31416838
[TBL] [Abstract][Full Text] [Related]
11. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.
Yang L; Xu JF; Kang Q; Li AQ; Jin P; Wang X; He YQ; Li N; Cheng T; Sheng JQ
PLoS One; 2017; 12(1):e0169124. PubMed ID: 28046028
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis.
Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y
J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736
[TBL] [Abstract][Full Text] [Related]
14. Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.
Toyoda T; Tsukamoto T; Yamamoto M; Ban H; Saito N; Takasu S; Shi L; Saito A; Ito S; Yamamura Y; Nishikawa A; Ogawa K; Tanaka T; Tatematsu M
BMC Gastroenterol; 2013 Jul; 13():122. PubMed ID: 23899160
[TBL] [Abstract][Full Text] [Related]
15.
Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
[TBL] [Abstract][Full Text] [Related]
16. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer.
Aydın EM; Demir TD; Seymen N; Said SS; Oktem-Okullu S; Tiftikci A; Cicek B; Tokat F; Tozun N; Ince U; Sezerman U; Sayi-Yazgan A
Immunol Lett; 2021 Nov; 239():1-11. PubMed ID: 34363898
[TBL] [Abstract][Full Text] [Related]
17. A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.
He Q; Li G; Wang X; Wang S; Hu J; Yang L; He Y; Pan Y; Yu D; Wu Y
Cell Physiol Biochem; 2017; 42(4):1326-1335. PubMed ID: 28700998
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Interleukin-1β-511 C/T Polymorphism and Gastric Cancer in Chinese Populations: A Meta-Analysis.
Chen B; Luo MX; Zhou X; Lv Y; Su GQ
Med Sci Monit; 2016 May; 22():1742-50. PubMed ID: 27215350
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis.
Xiao S; Li S; Zhou L; Jiang W; Liu J
J Gastroenterol; 2019 Mar; 54(3):226-237. PubMed ID: 30251121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
